Joseph Cox

Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study

Joseph J. Eron, Bonaventura Clotet, J. Durant et al. · The Journal of Infectious Diseases · 2012 · 312 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis

Darrell H. S. Tan, Mark Hull, Deborah Yoong et al. · Canadian Medical Association Journal · 2017 · 227 citations · Full text

Public Health, Infectious Disease Control, Preventive Medicine +13

Cohort Profile: The Canadian HIV-Hepatitis C Co-infection Cohort Study

Marina B. Klein, Sahar Saeed, Hong Yang et al. · International Journal of Epidemiology · 2009 · 95 citations · Full text

Medicine, Infectious Diseases, Clinical Epidemiology +16

Circulating (1→3)-β-D-glucan Is Associated With Immune Activation During Human Immunodeficiency Virus Infection

Vikram Mehraj, Rayoun Ramendra, Stéphane Isnard et al. · Clinical Infectious Diseases · 2019 · 85 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

HIV status of sexual partners is more important than antiretroviral treatment related perceptions for risk taking by HIV positive MSM in Montreal, Canada

Joseph Cox · Sexually Transmitted Infections · 2004 · 82 citations · Full text

Public Health, Health Behavior, Hiv Control +16